Implication of Oxysterols and Phytosterols in Aging and Human Diseases

Gérard Lizard

$456.95 $365.52

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer International Publishing AG
02 December 2023

Medical research; Oncology; Biochemistry; Lipids; Cellular biology (cytology)

Series: Advances in Experimental Medicine and Biology

This book provides basic knowledge of the biology, chemistry, and function of oxysterols and its derivatives as well as of phytosterols in numerous human diseases.

The book is divided into six sections and begins with an introduction to the biological and chemical properties of oxysterols and its derivatives as well as phytosterols, their synthesis, and the methods currently used for their detection in various biospecimens. The following section discusses in detail the various effects of oxysterols on numerous human diseases, including infectious diseases, inflammatory and autoimmune diseases, atherosclerosis, and cancer, as well as neurological and neuropsychiatric disorders. Importantly, the potential of oxysterols as biomarkers for some of these diseases is also highlighted. The book concludes with an outlook on the pharmacological and nutritional effects of oxysterols and phytosterols and their potential use by the food, and pharmaceutical industries.

Aiming to provide an in-depth overview of the biological and the chemical properties of oxysterols and phytosterols and their implications for human health, this book will be of interest to basic and clinical scientists, as well as to anyone working in the food or pharmaceutical industry who is exploring the potential of oxysterols and phytosterols.

Edited by: Gérard Lizard
Imprint: Springer International Publishing AG
Country of Publication: Switzerland
Edition: 2024 ed.
Volume: 1440
Dimensions: Height: 254mm, Width: 178mm,
Weight: 1.092kg
ISBN: 9783031438820
ISBN 10: 3031438825
Series: Advances in Experimental Medicine and Biology
Pages: 462
Publication Date: 02 December 2023
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Gérard Lizard is an INSA-Lyon (France) biochemist engineer, PhD in Molecular and Cellular Biology and PhD in Human Biology. After a post-doc in pharmaceutical industry, he was recruited to INSERM in 1991 and since 2012 has been director of the Biochemistry Laboratory 'Peroxisome, Inflammation and Lipid Metabolism' at the University of Burgundy (Dijon, France). He was one of the first researchers to work on cell death by apoptosis associated with oxidative stress in the field of atherosclerosis, which led him to demonstrate that certain oxidized derivatives of cholesterol (oxysterols) induce a mode of cell death by oxiapoptophagy characterized by oxidative stress, apoptosis and autophagy. Gérard Lizard has gradually oriented his research on aging (biogerontology) and the pathophysiology of age-related diseases by focusing on the lipotoxicity of oxysterols and the impact on organelles (mitochondria, peroxisome). Gérard Lizard (Inserm Researcher) has been the director of 20 PhD theses and is the co-funding member of the European Network for Oxysterol Research (ENOR).